Currently out of the existing stock ratings of Larry Biegelsen, 362 are a BUY (65.82%), 180 are a HOLD (32.73%), 8 are a SELL (1.45%).

Larry Biegelsen

Work Performance Price Targets & Ratings Chart

Analyst Larry Biegelsen, currently employed at WELLS FARGO, carries an average stock price target met ratio of 68.26% that have a potential upside of 16.4% achieved within 185 days.

Larry Biegelsen’s has documented 1,143 price targets and ratings displayed on 22 stocks. The coverage is on Healthcare, Communication Services sectors.

Most recent stock forecast was given on BDX, Becton Dickinson and Company at 07-Aug-2026.

Wall Street Analyst Larry Biegelsen

Analyst best performing recommendations are on NPCE (NEUROPACE).
The best stock recommendation documented was for NPCE (NEUROPACE) at 5/17/2021. The price target of $25 was fulfilled within 1 day with a profit of $3.28 (15.1%) receiving and performance score of 151.01.

Average potential price target upside

of $95.2 (25.05%) on EAR (EARGO ).
of $51.44 (23.13%) on PODD (INSULET).
of $38.71 (19.12%) on SYK (STRYKER).

ALC Alcon AG BDX Becton Dickinson and Company BSX Boston Scientific Corp DXCM DexCom EAR Eargo GKOS Glaukos Corp GMED Globus Medical ISRG Intuitive Surgical LUNG Pulmonx Corp MMSI Merit Medical Systems NPCE Neuropace NVRO Nevro Corp SWAV Shockwave Medical TFX Teleflex TNDM Tandem Diabetes Care ZBH Zimmer Biomet Holdings NUVA NuVasive PODD Insulet EW Edwards Lifesciences Corp ABT Abbott Laboratories EA Electronic Arts LNTH Lantheus Holdings

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

David Adlington (JPMORGAN)